Indian Pharmaceutical Industry is witnessing sea changes. With China + 1 strategy, India Pharma Companies are at inflection points. Amidst this, Indian Pharma companies are trying to expand its wings to strengthening...
Eris Lifesciences acquires trademark Zomelis from Novartis AG for $13 mn
Eris Lifesciences on Tuesday announced acquisition of the trademark Zomelis, for Vildagliptin-based formulations, and its associated trademarks from Novartis AG, Switzerland, for a consideration of $13 million (roughly...
Cipla plans acquisitions to enter new therapies, boost Africa business
Cipla is taking the acquisition and product in-licensing route to consolidate its business in Africa, the company’s second-largest market after India. Africa contributed 22 per cent to Cipla’s consolidated revenue in...
Strides to merge its Australian biz with Canadian drugmaker Apotex
Indian pharmaceutical company Strides Shasun on Wednesday said that it would merge its Australian business with the local operations of Canadian drugmaker Apotex Inc to create the country’s largest generics drugmaker by...
Eris Life to acquire Strides’ India business for Rs 500 crore
Bengaluru-based drug maker Strides Shasun has agreed to sell its domestic branded formulations business to Ahmedabad-based Eris Lifesciences for Rs 500 crore, joining a select league of Indian pharmaceuticals firms...
Stride’s DEMERGER TO FOCUS ON ANIMAL API
Strides Shasun Ltd (Stride), is a vertically integrated global pharmaceutical company headquartered in Bangalore. Stride has four business verticals, viz., regulated markets, merging markets, institutional business and...
KKR may back Peepul Capital’s Sandeep Reddy for acquisition of Medall Healthcare
Peepul Capital co-founder Sandeep Reddy may have found an ally in private equity firm KKR & Co. in his effort to buy out diagnostics firm Medall Healthcare Pvt. Ltd, two people close to the development said. In a...
Cipla in talks to sell animal health unit
Mumbai: Cipla Ltd, India’s second-largest drugmaker by revenue, is in discussions to sell Cipla Vet, its animal health division, according to two persons with knowledge of the development. The company, which has been in...
Fosun agrees to buy KKR-backed Indian drugmaker Gland Pharma for up to $1.3 bn
HONG KONG/MUMBAI: Shanghai Fosun Pharmaceutical Group Co Ltd has agreed to buy an 86 percent stake in Gland Pharma – backed by KKR & Co LP – for up to $1.3 billion, India’s largest inbound...
Small is Beautiful
While big ticket acquisitions like the $12.7-billion Tata Steel-Corus deal may draw major headlines and peer’s envy, it is small ticket deals like Dabur buying Balsara group for $35 million or Emani acquiring Zandu...
Strides gets to buy Sun Pharma’s two divisions
Strides Shasun on Tuesday got Commission of Indi’s (CCI’s) nod to acquire Sun Pharmaceutical’s two business divisions in India for Rs 165 crore. In September last year, Sun Pharma and Strides signed an...
Sept 2015 : M&A Happenings at Bombay High Court
Industry-wise breakup of the schemes filed is as follows: Industry No. of Deals August 2015 July 2015 Agriculture 1 2 Financial Services 1 2 Investments 2 5 Information Technology 4 6 Infrastructure 1 – Food...